> HEB – The PR makes it sound like the compliance was in doubt, so reaching compliance would deserve a PR<
Yes, a PR was warranted to say they’d regained Amex compliance. It was the style of the PR—touting the lack of non-compliance as a big deal and using the PR as a venue for vacuous pumping—that I singled out for ridicule.
HEB is a total scam but it does have impressive staying power. It will be gone from the biotech scene in due course but it’s hard to say exactly when.
Market Data 
Markets 
AI
